TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11961329

Group type: EXPERIMENTAL
Intervention: 200 ml tap water with 1.0 mg F
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 200 ml standard milk with 1.0 mg F
Number of subjects: 18

Group type: COMPARATOR
Intervention: 200 ml standard milk
Number of subjects: 18

Group type: COMPARATOR
Intervention: 200 ml F‐free tap water
Number of subjects: 18
Study: 10874381

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular intramuscular (i.m.) injections of opioid analgesia
Number of subjects: 0
Study: 8768863

Group type: EXPERIMENTAL
Intervention: Antithyroid drugs for 18 months
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Radioiodine (iodine-131) treatment
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 179
Study: 1913523

Group type: EXPERIMENTAL
Intervention: Specimen sonication and multiparameter ploidy analysis (MPPA)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Multiparameter ploidy analysis (MPPA)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Tetraploid tumors
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Ploidy and %S
Number of subjects: 167
Study: 6416664

Group type: EXPERIMENTAL
Intervention: Total lymphoid fields (TLI)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Involved field (IF)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Extended field (EF)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Megavoltage irradiation (general treatment)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Nodular Histiocytic (NH)
Number of subjects: 124
Study: 30728951

Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Calcium hydroxide (CH)
Number of subjects: 36
Study: 26464453

Group type: EXPERIMENTAL
Intervention: 0.06 mg/kg Sildenafil (Sild-L group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg Sildenafil (Sild-H group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 39
Study: 25012407

Group type: EXPERIMENTAL
Intervention: Clutter condition
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-clutter condition
Number of subjects: 34
Study: 22847059

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg once daily for 6 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: COMPARATOR
Intervention: Rosiglitazone vs Placebo
Number of subjects: 35
Study: 19625385

Group type: EXPERIMENTAL
Intervention: D2‐like agonist (Bromocriptine, 1.25 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: D2‐like antagonist (Sulpiride, 400 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17360794

Group type: EXPERIMENTAL
Intervention: Computer-generated tailored written information
Number of subjects: 138

Group type: COMPARATOR
Intervention: Generic written information
Number of subjects: 138
Study: 16373945

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet with 30% protein, 30% fat, and 40% carbohydrate; increased physical activity
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Hypocaloric diet and increased physical activity
Number of subjects: 70
Study: 12200242

Group type: EXPERIMENTAL
Intervention: British subjects over 50 years old
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: British women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: British men
Number of subjects: 0

Group type: COMPARATOR
Intervention: US NHANES III data
Number of subjects: 0
Study: 10456967

Group type: EXPERIMENTAL
Intervention: Multipuncture method (Heaf gun)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Intradermal method
Number of subjects: 169
Study: 7794875

Group type: COMPARATOR
Intervention: Western-type control diet for six weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Modified diet with 70% of the fat replaced by palm oil
Number of subjects: 38
Study: 2190547

Group type: EXPERIMENTAL
Intervention: 2% MK-927
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.5% MK-927
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.125% MK-927
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2% MK-927 (part C)
Number of subjects: 27
Study: 574397

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 31375422

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 4398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4398
Study: 27778256

Group type: EXPERIMENTAL
Intervention: Trans-perineal repair with limited internal sphincterotomy (group II)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Trans-perineal repair alone (group I)
Number of subjects: 62
Study: 26223543

Group type: EXPERIMENTAL
Intervention: Adalimumab (24 mg/m², maximum dose 40 mg every other week)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 46
Study: 23500260

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg twice daily
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 21713700

Group type: EXPERIMENTAL
Intervention: Antecolic gastroenteric anastomosis (group A, 20 cases)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Retrocolic gastroenteric anastomosis (group B, 20 cases)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Antecolic and retrocolic anastomosis (both groups)
Number of subjects: 40
Study: 19281922

Group type: EXPERIMENTAL
Intervention: Rosuvastatin therapy
Number of subjects: 6500000

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 6500000
Study: 17407516

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg/day for 2 weeks before and after TURP, or 4 weeks before and 2 weeks after TURP
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 214
Study: 15184247

Group type: EXPERIMENTAL
Intervention: Celecoxib (100 or 400 mg twice daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 11167590

Group type: EXPERIMENTAL
Intervention: Orthopaedic management/patient‐focused care unit (OMPFCU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care in the orthopaedic surgery wards
Number of subjects: 0
Study: 9605372

Group type: EXPERIMENTAL
Intervention: Autotransfusion of shed mediastinal blood every hour for 18 hours (Group I)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Accumulation of shed mediastinal blood for 4 hours followed by autotransfusion every hour for the next 14 hours (Group II)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: In vitro study with stimulation (PHA and E. coli LPS)
Number of subjects: 23
Study: 8809927

Group type: EXPERIMENTAL
Intervention: Graded activation intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 103
Study: 2109729

Group type: EXPERIMENTAL
Intervention: Terlipressin plus sublingual nitroglycerin (group I)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Balloon tamponade (group II)
Number of subjects: 34
Study: 7013560

Group type: EXPERIMENTAL
Intervention: Ketamine combined with diazepam
Number of subjects: 64
Study: 29020472

Group type: EXPERIMENTAL
Intervention: Active tDCS combined with SOP CRT
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham tDCS combined with SOP CRT
Number of subjects: 33
Study: 28683809

Group type: EXPERIMENTAL
Intervention: TAU plus the offer of an intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 24916808

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Granule (BHG) with baseline levodopa and benserazide (Madopar)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo with baseline levodopa and benserazide (Madopar)
Number of subjects: 120
Study: 26265273

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5mg
Number of subjects: 1053

Group type: COMPARATOR
Intervention: iDMT
Number of subjects: 1053
Study: 22525474

Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 91

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 91
Study: 19415122

Group type: EXPERIMENTAL
Intervention: WR279,396 applied twice a day for 20 days
Number of subjects: 92

Group type: COMPARATOR
Intervention: Vehicle-placebo
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: WR279,396
Number of subjects: 92
Study: 17319806

Group type: EXPERIMENTAL
Intervention: Coordinated care model
Number of subjects: 4603

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4603
Study: 15543027

Group type: EXPERIMENTAL
Intervention: Estrogen therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testosterone therapy (combined with estrogen)
Number of subjects: 0
Study: 11201419

Group type: EXPERIMENTAL
Intervention: Holding and sucrose taste (holding and sucrose group)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Holding and water taste (holding group)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: No holding and sucrose taste (sucrose group)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No holding and water taste (control participants)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 85
Study: 8776361

Group type: EXPERIMENTAL
Intervention: Topical potent glucocorticoid treatment (betamethasone-17-valerate) applied twice a day for 3 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment
Number of subjects: 28
Study: 1415406

Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation over the fetal vertex (n = 115)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation over the fetal breech (n = 90)
Number of subjects: 205
Study: 3935463

Group type: EXPERIMENTAL
Intervention: Glibenclamide instilled into the stomach
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glibenclamide instilled into the duodenum
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glibenclamide instilled into the colon
Number of subjects: 14
Study: 30950928

Group type: EXPERIMENTAL
Intervention: Original abutments (Group I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonoriginal abutments (Group II)
Number of subjects: 20
Study: 29845187

Group type: EXPERIMENTAL
Intervention: Words Sequence Test (WST) with a 4-word sequence
Number of subjects: 52

Group type: COMPARATOR
Intervention: Current speech-in-noise tests (control group)
Number of subjects: 52
Study: 27261995

Group type: EXPERIMENTAL
Intervention: Active group music therapy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Receptive group music therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Group counseling
Number of subjects: 14
Study: 24226487

Group type: EXPERIMENTAL
Intervention: Propofol TCI
Number of subjects: 80

Group type: COMPARATOR
Intervention: Thiopental TCI
Number of subjects: 80
Study: 22827903

Group type: EXPERIMENTAL
Intervention: Prevention intervention for women offenders
Number of subjects: 344

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 344
Study: 21166627

Group type: EXPERIMENTAL
Intervention: Volume assured non‐invasive ventilation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pressure preset non‐invasive ventilation
Number of subjects: 25
Study: 19674695

Group type: EXPERIMENTAL
Intervention: Custom-made flexible orthotics with the same exercise program
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no orthotics) with the same exercise program
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 13
Study: 15960063

Group type: EXPERIMENTAL
Intervention: APN prenatal care delivered in women's homes
Number of subjects: 83
Study: 12071338

Group type: EXPERIMENTAL
Intervention: Insulin treatment in untreated type 1 patients
Number of subjects: 298

Group type: COMPARATOR
Intervention: Untreated type 1 patients
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Insulin therapy adjustment in males aged 16-59 years
Number of subjects: 298

Group type: COMPARATOR
Intervention: Insulin therapy in women with insufficient glucose control
Number of subjects: 298

Group type: COMPARATOR
Intervention: Type 2 diabetic patients (men over 40 years)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Type 2 diabetic patients (women)
Number of subjects: 298
Study: 10721060

Group type: EXPERIMENTAL
Intervention: Indole-3-pyruvic acid (IPA)
Number of subjects: 0
Study: 7735265

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1755249

Group type: EXPERIMENTAL
Intervention: Subhepatic drainage
Number of subjects: 56

Group type: COMPARATOR
Intervention: No subhepatic drainage (Control)
Number of subjects: 56
Study: 6620013

Group type: EXPERIMENTAL
Intervention: Chest physical therapy (CPT) administered by a parent, regular twice daily basis
Number of subjects: 8
Study: 31088511

Group type: EXPERIMENTAL
Intervention: Strong electroacupuncture (EA) (> 2 mA)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Weak electroacupuncture (EA) (< 0.5 mA)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Sham electroacupuncture (non-acupoint)
Number of subjects: 301
Study: 30526648

Group type: EXPERIMENTAL
Intervention: Buprenorphine 32 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Buprenorphine 64 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Buprenorphine 96 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 26820776

Group type: EXPERIMENTAL
Intervention: Health-based messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Descriptive social norm-based messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition messages
Number of subjects: 0
Study: 24726614

Group type: EXPERIMENTAL
Intervention: Platinum-based regimens
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Parametric survival model
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Simulations
Number of subjects: 534
Study: 22016358

Group type: EXPERIMENTAL
Intervention: Mediterranean diet + CoQ (Med + CoQ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saturated fatty acid‐rich diet (SFA)
Number of subjects: 20
Study: 19160389

Group type: EXPERIMENTAL
Intervention: Persistent allergic rhinitis patients (PER)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Moderate/severe PER patients with SRH
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nasal nitric oxide (nNO) levels in PER patients
Number of subjects: 49

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 49
Study: 18372697

Group type: EXPERIMENTAL
Intervention: Exercise (EX) - treadmill running 3-4 days per week for 40-min followed by 10-min of static LBNP, and resistive exercise on a flywheel device every 3rd day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (non-exercisers)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (0.3 mg sublingual administration)
Number of subjects: 24
Study: 15902411

Group type: EXPERIMENTAL
Intervention: General Health Questionnaire (GHQ)
Number of subjects: 7357

Group type: COMPARATOR
Intervention: Revised Clinical Interview Schedule (CIS-R)
Number of subjects: 7357
Study: 11774111

Group type: EXPERIMENTAL
Intervention: Vitamin E hemodialyzer (CL‐EE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control dialyzer
Number of subjects: 10
Study: 9702435

Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times a day with a mildly hypocaloric diet
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo with a mildly hypocaloric diet
Number of subjects: 391
Study: 8026408

Group type: EXPERIMENTAL
Intervention: High VNS
Number of subjects: 67

Group type: COMPARATOR
Intervention: Low VNS
Number of subjects: 67
Study: 3377953

Group type: EXPERIMENTAL
Intervention: Positive suggestions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonsense suggestions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seaside sounds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sounds from the operating theatre
Number of subjects: 0
Study: 31969443

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with ropivacaine 0.5% and epinephrine (20 mL unilateral or 16 mL/side for bilateral)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paravertebral nerve block (PVB) with ropivacaine 0.5% and epinephrine (20 mL unilateral or 16 mL/side for bilateral)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paravertebral nerve block (PVB)
Number of subjects: 100
Study: 31374368

Group type: EXPERIMENTAL
Intervention: 8-week home-based physical activity intervention (twice weekly supervised resistance training and unsupervised walking program)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study: 28793991

Group type: EXPERIMENTAL
Intervention: Ready-to-use supplemental food (RUSF)
Number of subjects: 1828

Group type: COMPARATOR
Intervention: Corn-soy blend with UNIMMAP (CSB+)
Number of subjects: 1828

Group type: COMPARATOR
Intervention: Corn-soy blend with iron and folic acid (CSB+)
Number of subjects: 1828
Study: 25730522

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Alcohol Edu for Sanctions
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Alcohol 101 Plus
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1040
Study: 22662393

Group type: COMPARATOR
Intervention: Enhanced Cued Recall Test - Computer-based
Number of subjects: 77

Group type: COMPARATOR
Intervention: Line Orientation Test - Computer-based
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Paper-and-pencil tests
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Total score difference between modalities
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Computer-based tests
Number of subjects: 77
Study: 20528005

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 2000 mg twice daily with standard breakfast
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 2000 mg twice daily with high-fat breakfast
Number of subjects: 8

Group type: COMPARATOR
Intervention: Quercetin 500 mg twice daily
Number of subjects: 8

Group type: COMPARATOR
Intervention: 5% alcohol 100 mL
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Trans-resveratrol 2000 mg twice daily
Number of subjects: 8
Study: 18579903

Group type: EXPERIMENTAL
Intervention: 0 kg load (body mass only)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 20 kg load
Number of subjects: 18

Group type: COMPARATOR
Intervention: 40 kg load
Number of subjects: 18

Group type: COMPARATOR
Intervention: 60 kg load
Number of subjects: 18

Group type: COMPARATOR
Intervention: 80 kg load
Number of subjects: 18
Study: 16156492

Group type: EXPERIMENTAL
Intervention: Solution Focused Brief Therapy (SFBT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Common Factors Therapy (CFT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Waiting List Control (WC)
Number of subjects: 55
Study: 11950019

Group type: EXPERIMENTAL
Intervention: Home based exercise intervention package (exercise/information video, exercise progress chart, patient education booklet, AS exercise reminder stickers)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Home based exercise intervention package
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (follow-up)
Number of subjects: 200
Study: 10429566

Group type: EXPERIMENTAL
Intervention: Sodium chloride baths
Number of subjects: 73

Group type: COMPARATOR
Intervention: Common water baths
Number of subjects: 73
Study: 7772424

Group type: EXPERIMENTAL
Intervention: Ephedrine 0.6 mg kg‐1 body weight
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 98
Study: 2185693

Group type: EXPERIMENTAL
Intervention: Amphotericin B syrup 2,400 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Amphotericin B syrup 1,200 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Amphotericin B syrup 800 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Amphotericin B syrup 400 mg/day
Number of subjects: 36
Study: 7444371

Group type: EXPERIMENTAL
Intervention: Hog mucosa heparin
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Beef lung heparin
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no specific control mentioned)
Number of subjects: 129
Study: 30112721

Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 28
Study: 29523095

Group type: EXPERIMENTAL
Intervention: Health literacy (measured by Newest Vital Sign - NVS)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Patient activation (measured by Patient Activation Measure-13 - PAM-13)
Number of subjects: 247
Study: 26795764

Group type: EXPERIMENTAL
Intervention: Contralateral manual acupuncture (n=38) for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting list group receiving conventional orthopaedic therapy (n=42)
Number of subjects: 80
Study: 24907444

Group type: EXPERIMENTAL
Intervention: Altis Single Incision Sling System
Number of subjects: 113
Study: 22558370

Group type: EXPERIMENTAL
Intervention: 30-minute sessions of biofeedback‐assisted stress management training (SMT) while immersed in a horror/first‐person shooter game for three days
Number of subjects: 41

Group type: COMPARATOR
Intervention: No additional stress management training (SMT) for three days
Number of subjects: 41
Study: 20671098

Group type: EXPERIMENTAL
Intervention: 10 weeks of drug therapy combined with behavioral intervention (pelvic‐floor muscle exercises, UI prevention strategies, delayed voiding)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: 10 weeks of drug therapy combined with behavioral intervention
Number of subjects: 307

Group type: COMPARATOR
Intervention: 10 weeks of drug therapy only
Number of subjects: 307
Study: 18313371

Group type: EXPERIMENTAL
Intervention: 7.5 mg zopiclone (test)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 7.5 mg zopiclone (reference)
Number of subjects: 16